|
|
Volumn 2014, Issue , 2014, Pages
|
|
Compensatory mechanisms of pancreatic beta cells: Insights into the therapeutic perspectives for diabetes
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARF PROTEIN;
CYCLIN DEPENDENT KINASE INHIBITOR 2A;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
EXENDIN 4;
GLUCAGON LIKE PEPTIDE 1;
GLUCAGON LIKE PEPTIDE 1 RECEPTOR;
GLYCOSYLATED HEMOGLOBIN;
INCRETIN;
METFORMIN;
MICRORNA;
MITOGEN ACTIVATED PROTEIN KINASE 12;
POTASSIUM CHANNEL;
REPAGLINIDE;
ANTIDIABETIC AGENT;
CELL EXPANSION;
CELL SURVIVAL;
DIABETES MELLITUS;
DIABETIC PATIENT;
EDITORIAL;
ENDOPLASMIC RETICULUM STRESS;
GLYCEMIC CONTROL;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
INSULIN RELEASE;
MONOTHERAPY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PANCREAS ISLET BETA CELL;
PRIORITY JOURNAL;
UNFOLDED PROTEIN RESPONSE;
ADAPTATION;
CELL PROLIFERATION;
DRUG DESIGN;
DRUG EFFECTS;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
PATHOLOGY;
PATHOPHYSIOLOGY;
SIGNAL TRANSDUCTION;
ADAPTATION, PHYSIOLOGICAL;
CELL PROLIFERATION;
DIABETES MELLITUS;
DRUG DESIGN;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN-SECRETING CELLS;
MOLECULAR TARGETED THERAPY;
SIGNAL TRANSDUCTION;
|
|
EID: 84928769450
PISSN: 23146745
EISSN: 23146753
Source Type: Journal
DOI: 10.1155/2014/217387 Document Type: Editorial |
|
Times cited : (6)
|
|
References (0)
|
